OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $1,429,119 Invested

2024

ViewMind

Yaakov Stern, PhD

Investigating ViewMind ocular digital cognitive biomarkers and their relationship to tau and amyloid PET scans.

  • Funding Amount: $1,429,119
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Status: Active